SIRT3 and cancer: Thus, SIRT3 inhibitors are crucial for treating cancer due to their association with a poor prognosis, and SIRT3 inhibitors development methodologies are more varied compared to SIRT3 activators, including classic structure-based inhibitor design, chemical library-based inhibitor screening, substrate-based competitive inhibitor design, and coenzyme competitive inhibitor design 33.